Novation, a U.S. group purchasing organization serving the healthcare industry, has awarded Triad Isotopes with a contract to become one of its radiopharmaceutical suppliers.
Triad has been selected as a supplier of both high-energy and low-energy nuclear pharmacy products. The Novation contract is a five-year award to provide radiopharmaceutical products at negotiated prices to the VHA, UHC and Provista members.
Triad of Orlando, Fla., is one of three companies selected to provide low-energy products and one of four companies selected to serve high-energy customers for the period extending from July 2012 through June 2017.
Novation’s radiopharmaceutical distribution contract took effect on July 1.